2021 SFRO建议：放射治疗在原发性阴道癌治疗中的作用

2021-12-16 法国放射肿瘤学学会 Cancer Radiother

2021年12月，法国放射肿瘤学学会(SFRO)发布了放射治疗在原发性阴道癌治疗中的作用的建议。原发性阴道癌是一种罕见的肿瘤，外照射和近距离放疗是主要的治疗手段。

中文标题：

英文标题：

Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology

发布机构：

法国放射肿瘤学学会

发布日期：

2021-12-16

简要介绍：

2021年12月，法国放射肿瘤学学会(SFRO)发布了放射治疗在原发性阴道癌治疗中的作用的建议。原发性阴道癌是一种罕见的肿瘤，外照射和近距离放疗是主要的治疗手段。本文主要针对原发性阴道癌的外照射和近距离放疗的适应证和技术提供指导建议。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=d01ff1c002330efe, title=2021 SFRO建议：放射治疗在原发性阴道癌治疗中的作用, enTitle=Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology, guiderFrom=Cancer Radiother, authorId=0, author=, summary=2021年12月，法国放射肿瘤学学会(SFRO)发布了放射治疗在原发性阴道癌治疗中的作用的建议。原发性阴道癌是一种罕见的肿瘤，外照射和近距离放疗是主要的治疗手段。, cover=https://img.medsci.cn/2022120/1642649718974_1608702.jpg, journalId=0, articlesId=null, associationId=2275, associationName=法国放射肿瘤学学会, associationIntro=法国放射肿瘤学学会(SFRO,French society for radiation oncology), copyright=0, guiderPublishedTime=Thu Dec 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，法国放射肿瘤学学会(SFRO)发布了放射治疗在原发性阴道癌治疗中的作用的建议。原发性阴道癌是一种罕见的肿瘤，外照射和近距离放疗是主要的治疗手段。本文主要针对原发性阴道癌的外照射和近距离放疗的适应证和技术提供指导建议。</span></p>, tagList=[TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=6811, tagName=放射治疗), TagDto(tagId=121851, tagName=原发性阴道癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=105696, appHits=40, showAppHits=0, pcHits=458, showPcHits=105655, likes=1, shares=16, comments=6, approvalStatus=1, publishedTime=Thu Jan 20 11:32:43 CST 2022, publishedTimeString=2021-12-16, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Thu Jan 20 11:36:33 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Tue Jan 02 21:35:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 SFRO建议：放射治疗在原发性阴道癌治疗中的作用.pdf)])

2021 SFRO建议：放射治疗在原发性阴道癌治疗中的作用.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1192838, encodeId=68e411928384e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54615714086, createdName=ms2000001066939383, createdTime=Sat Feb 12 23:47:13 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186769, encodeId=92241186e6973, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 12:00:08 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186677, encodeId=edda11866e7dd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 21 07:29:19 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186549, encodeId=0c4c1186549ed, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48F235FCC9A89C79348E8F0C86D1EB0A/100, createdBy=bc3b2058734, createdName=香草优格, createdTime=Thu Jan 20 19:19:27 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
2022-02-12 ms2000001066939383

学习学习

130 0
[GetPortalCommentsPageByObjectIdResponse(id=1192838, encodeId=68e411928384e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54615714086, createdName=ms2000001066939383, createdTime=Sat Feb 12 23:47:13 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186769, encodeId=92241186e6973, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 12:00:08 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186677, encodeId=edda11866e7dd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 21 07:29:19 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186549, encodeId=0c4c1186549ed, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48F235FCC9A89C79348E8F0C86D1EB0A/100, createdBy=bc3b2058734, createdName=香草优格, createdTime=Thu Jan 20 19:19:27 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
2022-01-21 ms1000001107271726

学习学习

174 0
[GetPortalCommentsPageByObjectIdResponse(id=1192838, encodeId=68e411928384e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54615714086, createdName=ms2000001066939383, createdTime=Sat Feb 12 23:47:13 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186769, encodeId=92241186e6973, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 12:00:08 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186677, encodeId=edda11866e7dd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 21 07:29:19 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186549, encodeId=0c4c1186549ed, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48F235FCC9A89C79348E8F0C86D1EB0A/100, createdBy=bc3b2058734, createdName=香草优格, createdTime=Thu Jan 20 19:19:27 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
2022-01-21 微探

学习学习

149 0
[GetPortalCommentsPageByObjectIdResponse(id=1192838, encodeId=68e411928384e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54615714086, createdName=ms2000001066939383, createdTime=Sat Feb 12 23:47:13 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186769, encodeId=92241186e6973, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 12:00:08 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186677, encodeId=edda11866e7dd, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 21 07:29:19 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186549, encodeId=0c4c1186549ed, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48F235FCC9A89C79348E8F0C86D1EB0A/100, createdBy=bc3b2058734, createdName=香草优格, createdTime=Thu Jan 20 19:19:27 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
2022-01-20 香草优格

学习学习

161 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤指南

2021 SFRO建议：放射治疗在原发性阴道癌治疗中的作用

相关指南

科室

工具

服务